+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Alendronate"

From
Osteoporosis Drugs Market Report 2025 - Product Thumbnail Image

Osteoporosis Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Osteoporosis Treatment Market Report 2025 - Product Thumbnail Image

Osteoporosis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Postmenopausal Osteoporosis Treatment Market Report 2025 - Product Thumbnail Image

Postmenopausal Osteoporosis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Postmenopausal Osteoporosis - Pipeline Insight, 2025 - Product Thumbnail Image

Postmenopausal Osteoporosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
  • 11 Results (Page 1 of 1)
Loading Indicator

Alendronate is a drug used to treat endocrine and metabolic disorders. It is a bisphosphonate, a type of medication that helps to reduce the risk of fractures in people with osteoporosis. Alendronate works by slowing down the breakdown of bone and increasing bone density. It is also used to treat Paget's disease of bone, a condition that causes bones to become weak and brittle. Alendronate is available in both oral and intravenous forms. Alendronate is a widely used drug in the endocrine and metabolic disorders market. It is prescribed to millions of people worldwide and is one of the most commonly prescribed drugs for osteoporosis. Alendronate is also used to treat other bone-related conditions, such as hypercalcemia and hyperparathyroidism. Some companies in the Alendronate market include Merck, Novartis, Teva Pharmaceuticals, and Mylan. Show Less Read more